Cargando…
BMP4 overexpression induces the upregulation of APP/Tau and memory deficits in Alzheimer’s disease
Alzheimer’s disease (AD) is a chronic progressive degenerative disease of the nervous system. Its pathogenesis is complex and is related to the abnormal expression of the amyloid β (Aβ), APP, and Tau proteins. Evidence has demonstrated that bone morphogenetic protein 4 (BMP4) is highly expressed in...
Autores principales: | Zhang, Xiaoqing, Li, Juan, Ma, Li, Xu, Hui, Cao, Yun, Liang, Wei, Ma, Jia, Wang, Z. Peter, Li, Yuyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961014/ https://www.ncbi.nlm.nih.gov/pubmed/33723239 http://dx.doi.org/10.1038/s41420-021-00435-x |
Ejemplares similares
-
CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer’s Disease
por: Shentu, Yang-Ping, et al.
Publicado: (2018) -
DNA vaccines targeting amyloid-β oligomer ameliorate cognitive deficits of aged APP/PS1/tau triple-transgenic mouse models of Alzheimer’s disease
por: Sha, Sha, et al.
Publicado: (2022) -
Intranasal BMP9 Ameliorates Alzheimer Disease-Like Pathology and Cognitive Deficits in APP/PS1 Transgenic Mice
por: Wang, Zigao, et al.
Publicado: (2017) -
Zileuton Improves Memory Deficits, Amyloid and Tau Pathology in a Mouse Model of Alzheimer’s Disease with Plaques and Tangles
por: Chu, Jin, et al.
Publicado: (2013) -
Possible Mechanisms of Tau Spread and Toxicity in Alzheimer’s Disease
por: Zhang, Huiqin, et al.
Publicado: (2021)